Navigating Renin-Angiotensin System Inhibitors in Patients with Declines in eGFR

J Am Soc Nephrol. 2024 Oct 1;35(10):1309-1311. doi: 10.1681/ASN.0000000000000470. Epub 2024 Aug 13.

Authors

Rachel Shulman¹, Jordana B Cohen^{1

2}

Affiliations

¹ Renal-Electrolyte and Hypertension Division, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.
² Department of Biostatistics, Epidemiology, and Informatics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania.

PMID: 39137049
PMCID: PMC11452186 (available on 2025-10-01)
DOI: 10.1681/ASN.0000000000000470

No abstract available

Publication types

Editorial

MeSH terms

Angiotensin Receptor Antagonists / pharmacology
Angiotensin Receptor Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors* / pharmacology
Angiotensin-Converting Enzyme Inhibitors* / therapeutic use
Glomerular Filtration Rate*
Humans
Renal Insufficiency, Chronic / drug therapy
Renin-Angiotensin System* / drug effects
Renin-Angiotensin System* / physiology

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors

Grants and funding